These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2003332)

  • 1. Confidential unit exclusion (CUE) is just another test.
    Soloway HB
    Transfusion; 1991; 31(3):286-7. PubMed ID: 2003332
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of various methods of confidential unit exclusion in identifying potentially infectious blood donations.
    Loiacono BR; Carter GR; Carter CS; Leitman SF; Klein HG
    Transfusion; 1989; 29(9):823-6. PubMed ID: 2486748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission groups of French HIV seropositive blood donors (August 1985-December 1990). The French Blood Centers.
    Lefrère JJ; Pillonel J
    Nouv Rev Fr Hematol (1978); 1992; 34(6):455-7. PubMed ID: 1300545
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for HIV seropositivity among first-time blood donors in Zimbabwe.
    McFarland W; Mvere D; Shamu R; Katzenstein D
    Transfusion; 1998 Mar; 38(3):279-84. PubMed ID: 9563408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of donor self exclusion in repeat blood donors].
    Pastucha L; Andres J; Stangel W
    Beitr Infusionsther; 1990; 26():5-8. PubMed ID: 1703899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
    McFarland W; Mvere D; Katzenstein D
    AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the confidential unit exclusion form: the Canadian Blood Services experience.
    O'Brien SF; Fan W; Xi G; Yi QL; Goldman M
    Vox Sang; 2010 Feb; 98(2):138-44. PubMed ID: 19754523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current impact of the confidential unit exclusion option.
    Zou S; Notari EP; Musavi F; Dodd RY;
    Transfusion; 2004 May; 44(5):651-7. PubMed ID: 15104644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rising trend of HIV infection with special reference to blood donors.
    Wadia MR; Karve SR
    J Assoc Physicians India; 1992 Aug; 40(8):513-5. PubMed ID: 1308488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Questionable efficacy of confidential unit exclusion.
    Busch MP; Perkins HA; Holland PV; Doll LS; Petersen L
    Transfusion; 1990 Sep; 30(7):668-9. PubMed ID: 2402781
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential deferral criteria predictive of human immunodeficiency virus positivity among blood donors in Thailand.
    Kitayaporn D; Bejrachandra S; Chongkolwatana V; Chandanayingyong D; Weniger BG
    Transfusion; 1994 Feb; 34(2):152-7. PubMed ID: 8310487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whose blood is safer? The effect of the stage of the epidemic on screening for HIV.
    Litvak E; Siegel JE; Pauker SG; Lallemant M; Fineberg HV; Weinstein MC
    Med Decis Making; 1997; 17(4):455-63. PubMed ID: 9343804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of the confidential unit exclusion option.
    Petersen LR; Lackritz E; Lewis WF; Smith DS; Herrera G; Raimondi V; Aberle-Grasse J; Dodd RY
    Transfusion; 1994 Oct; 34(10):865-9. PubMed ID: 7940657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study.
    Korelitz JJ; Williams AE; Busch MP; Zuck TF; Ownby HE; Matijas LJ; Wright DJ
    Transfusion; 1994 Oct; 34(10):870-6. PubMed ID: 7940658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV seropositivity in Greek blood donors (1985-1990).
    Hatzidimitriou K; Kontopoulou I; Mandalaki T; Renieri N; Sofroniadou K; Politi C; Loizou K; Spiliotopoulou I; Gialeraki A; Panayotopoulou K
    Vox Sang; 1991; 61(3):215-6. PubMed ID: 1807063
    [No Abstract]   [Full Text] [Related]  

  • 16. Current risk of transfusion-associated human immunodeficiency virus infection.
    Menitove JE
    Arch Pathol Lab Med; 1990 Mar; 114(3):330-4. PubMed ID: 2407223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus infection related to blood transfusion service.
    Sengupta B; De M; Lahiri P; Bhattacharya DK
    Indian J Med Res; 1994 Nov; 100():223-4. PubMed ID: 7829155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 infection in Italian blood donors during a 5 year surveillance.
    Ferroni P; Mascolo G; Zaninetti M; Colzani D; Pasquali M; Azzario F
    Eur J Epidemiol; 1992 Nov; 8(6):885-6. PubMed ID: 1294399
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening of blood donations for HIV-1 antibody: 1985-1991.
    Gunson HH; Rawlinson VI
    CDR (Lond Engl Rev); 1991 Dec; 1(13):R144-6. PubMed ID: 1669759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence for seropositivity for HIV, hepatitis B and hepatitis C in blood donors].
    Rivera-López MR; Zavala-Méndez C; Arenas-Esqueda A
    Gac Med Mex; 2004; 140(6):657-60. PubMed ID: 15633577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.